CTMedic: Perhaps it's more a tale of 2 press releases, one artfully composed to produce lemonade from the involved lemons, and the other woefully unable to exploit the positive info delivered by the DSMB. Leronlimab has put CYDY on 3rd base and management thinks it hit a triple.